Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 1
2014 2
2015 1
2017 1
2018 3
2019 1
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean rosaline mishra[Author] (32 results)?
HER3 Alterations in Cancer and Potential Clinical Implications.
Kilroy MK, Park S, Feroz W, Patel H, Mishra R, Alanazi S, Garrett JT. Kilroy MK, et al. Among authors: mishra r. Cancers (Basel). 2022 Dec 14;14(24):6174. doi: 10.3390/cancers14246174. Cancers (Basel). 2022. PMID: 36551663 Free PMC article. Review.
Current Advances in the Treatment of BRAF-Mutant Melanoma.
Patel H, Yacoub N, Mishra R, White A, Long Y, Alanazi S, Garrett JT. Patel H, et al. Among authors: mishra r. Cancers (Basel). 2020 Feb 19;12(2):482. doi: 10.3390/cancers12020482. Cancers (Basel). 2020. PMID: 32092958 Free PMC article. Review.
Osteopontin as a therapeutic target for cancer.
Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, Gorain M, Kale S, Kumar D, Kumar S, Totakura KV, Roy G, Sharma P, Shetti D, Soundararajan G, Thorat D, Tomar D, Nalukurthi R, Raja R, Mishra R, Yadav AS, Kundu GC. Bandopadhyay M, et al. Among authors: mishra r. Expert Opin Ther Targets. 2014 Aug;18(8):883-95. doi: 10.1517/14728222.2014.925447. Epub 2014 Jun 4. Expert Opin Ther Targets. 2014. PMID: 24899149 Review.
Activating HER3 mutations in breast cancer.
Mishra R, Alanazi S, Yuan L, Solomon T, Thaker TM, Jura N, Garrett JT. Mishra R, et al. Oncotarget. 2018 Jun 12;9(45):27773-27788. doi: 10.18632/oncotarget.25576. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963236 Free PMC article.
Osteopontin: a potentially important therapeutic target in cancer.
Ahmed M, Behera R, Chakraborty G, Jain S, Kumar V, Sharma P, Bulbule A, Kale S, Kumar S, Mishra R, Raja R, Saraswati S, Kaur R, Soundararajan G, Kumar D, Thorat D, Sanyal M, Ramdasi A, Ghosh P, Kundu GC. Ahmed M, et al. Among authors: mishra r. Expert Opin Ther Targets. 2011 Sep;15(9):1113-26. doi: 10.1517/14728222.2011.594438. Epub 2011 Jul 25. Expert Opin Ther Targets. 2011. PMID: 21718227 Review.
HER3 signaling and targeted therapy in cancer.
Mishra R, Patel H, Alanazi S, Yuan L, Garrett JT. Mishra R, et al. Oncol Rev. 2018 May 16;12(1):355. doi: 10.4081/oncol.2018.355. eCollection 2018 Jan 30. Oncol Rev. 2018. PMID: 30057690 Free PMC article.
19 results